ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $529,409 | -28.7% | 28,417 | -0.6% | 0.02% | -25.0% |
| Q2 2023 | $742,846 | +38.1% | 28,593 | +52.6% | 0.03% | +33.3% |
| Q1 2023 | $538,012 | -2.0% | 18,733 | +1.0% | 0.02% | -8.7% |
| Q4 2022 | $549,050 | -2.3% | 18,549 | -21.4% | 0.02% | -8.0% |
| Q3 2022 | $562,000 | +6.0% | 23,600 | -0.6% | 0.02% | +13.6% |
| Q2 2022 | $530,000 | +54.5% | 23,734 | +73.8% | 0.02% | +46.7% |
| Q1 2022 | $343,000 | -38.4% | 13,655 | -12.2% | 0.02% | -25.0% |
| Q4 2021 | $557,000 | -28.6% | 15,555 | -15.1% | 0.02% | -28.6% |
| Q3 2021 | $780,000 | -5.1% | 18,316 | -3.5% | 0.03% | 0.0% |
| Q2 2021 | $822,000 | +3.1% | 18,980 | -2.9% | 0.03% | +12.0% |
| Q1 2021 | $797,000 | -12.2% | 19,548 | -2.6% | 0.02% | -16.7% |
| Q4 2020 | $908,000 | +66.3% | 20,064 | +30.0% | 0.03% | +42.9% |
| Q3 2020 | $546,000 | -49.9% | 15,435 | -46.6% | 0.02% | -40.0% |
| Q2 2020 | $1,090,000 | +51.8% | 28,897 | +16.3% | 0.04% | +84.2% |
| Q1 2020 | $718,000 | – | 24,850 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |